Guidelines of care for sclerotherapy treatment of varicose and telangiectatic leg veins

Journal of the American Academy of Dermatology

Volumn 34, Issue 3, 1996, Pages 523-528

  Drake, Lynn A ^b   Dinehart, Scott M ^b   Goltz, Robert W ^b   Graham, Gloria F ^b   Hordinsky, Maria K ^b   Lewis, Charles W ^b   Pariser, David M ^b   Skouge, John W ^b   Webster, Stephen B ^b   Whitaker, Duane C ^b   Butler, Barbara ^b   Lowery, Barbara J ^b   Goldman, Mitchel P ^b   Duffy, David M ^b   Sadick, Neil S ^b   Weiss, Robert A ^b  

^a AMERICAN ACADEMY OF DERMATOLOGY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PROTOCOL; DIAGNOSTIC APPROACH ROUTE; HUMAN; LEG COMPRESSION; LEG VARICOSIS; PATIENT EDUCATION; PRIORITY JOURNAL; SCLEROTHERAPY; TELANGIECTASIA; TREATMENT PLANNING;

EID: 13344269027     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(96)90467-3     Document Type: Article

References (23)

1. Bergan JJ, Goldman MP, eds. Varicose veins and telangiectasias: diagnosis and treatment. St Louis: Quality Medical Publishing, 1993.
2. Bergan JJ, Yao JST, eds. Venous disorders. Philadelphia: WB Saunders, 1991.
3. Biegeleisen K. Primary lower extremity telangjectasis: relationship of size to color. Angiology 1987;38:760-8.
4. Bodian G, Goldman MP, eds. Special issue on sclerotherapy. J Dermatol Surg Oncol 1989;15:131-225.
5. Bohler-Sommeregger K, Karnel F, Schuller-Petrovic S, et al. Do telangiectases communicate with the deep venous system? J Dermatol Surg Oncol 1992;18:403-6.
6. Braverman IM. Ultrastructure and organization of the cutaneous microvasculature in normal and pathologic states. J Invest Dermatol 1989;93(suppl):2S-9S.
7. Browse NL, Burnand KG, Thomas ML. Diseases of the veins: pathology, diagnosis and treatment. London: Edward Arnold, 1988.
8. Carlin MC, Ratz JL. Treatment of telangiectasia: comparison of sclerosing agents. J Dermatol Surg Oncol 1987;13:1181-4.
9. deGroot WP. Practical phlebology: sclerotherapy of large veins. J Dermatol Surg Oncol 1991;17:589-95.
10. Duffy DM. Small vessel sclerotherapy: an overview. Adv Dermatol 1988;3:221-42.
11. Engel A, Johnson ML, Haynes SG. Health effects of sunlight exposure in the United States: Results from the first National Health and Nutrition Examination Survey, 1971-74. Arch Dermatol 1988;124:72-9.
12. Fegan WG. The complications of compression sclerotherapy. Practitioner 1971;207:797-9.
13. Fegan WG. Continuous compression technique of injecting varicose veins. Lancet 1963;2:109-12.
14. Fraser IA, Perry EP, Hatton M, et al. Prolonged bandaging is not required following sclerotherapy of varicose veins. Br J Surg 1985;72:488-90.
15. Gallagher PG. Varicose veins - primary treatment with sclerotherapy: a personal appraisal. J Dermatol Surg Oncol 1992;18:39-42.
16. Goldman MP. Sclerotherapy: treatment of varicose and telangiectatic leg veins. St Louis: Mosby-Year Book, 1991.
17. Goldman MP, Bennett RG. Treatment of telangiectasia: a review. J AM ACAD DERMATOL 1987;17:167-82.
18. Imhoff E, Stemmer R. Classification and mechanism of action of sclerosing agents. Phlebologie 1969;22:145-8.
19. Puissegur Lupo ML. Sclerotherapy: review of results and complications in 200 patients. J Dermatol Surg Oncol 1989;15:214-9.
20. Sadick NS. Sclerotherapy of varicose and telangiectatic leg veins: minimal sclerosant concentration of hypertonic saline and its relationship to vessel diameter. J Dermatol Surg Oncol 1991;17:65-70.
21. Thibault P, Wlodarczyk J. Postsclerotherapy hyperpigmentation: the role of serum ferritin levels and the effectiveness of treatment with the copper vapor laser. J Dermatol Surg Oncol 1992;18:47-52.
22. Weiss RA, Weiss MA. Resolution of pain associated with varicose and telangiectatic leg veins after compression sclerotherapy. J Dermatol Surg Oncol 1994;16:333-6.
23. Weiss RA, Weiss MA. Sclerotherapy. In: Wheeland RG, ed. Cutaneous surgery. Philadelphia: WB Saunders, 1994:951-81.